38
Participants
Start Date
March 31, 2010
Primary Completion Date
March 31, 2013
Study Completion Date
March 31, 2013
Aurora B/C kinase inhibitor GSK1070916A
laboratory biomarker analysis
pharmacological study
diffusion-weighted magnetic resonance imaging + PET CT
fludeoxyglucose F 18 dynomic contrast
Leeds Cancer Centre at St. James's University Hospital, Leeds
Barts and the London School of Medicine, London
Lead Sponsor
Cancer Research UK
OTHER